AMGN vs. THC: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AMGN and THC, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
AMGN dominates in value with a market cap of 145.90 billion USD, eclipsing THC’s 15.12 billion USD by roughly 9.65×.
THC carries a higher beta at 1.63, indicating it’s more sensitive to market moves, while AMGN remains steadier at 0.50.
| Symbol | AMGN | THC |
|---|---|---|
| Company Name | Amgen Inc. | Tenet Healthcare Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Care Facilities |
| CEO | Mr. Robert A. Bradway | Dr. Saumya Sutaria M.D. |
| Price | 271.34 USD | 162.83 USD |
| Market Cap | 145.90 billion USD | 15.12 billion USD |
| Beta | 0.50 | 1.63 |
| Exchange | NASDAQ | NYSE |
| IPO Date | June 17, 1983 | March 17, 1980 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of AMGN and THC over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AMGN and THC, please refer to the table below.
| Symbol | AMGN | THC |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 24.60 | 10.55 |
| Forward PEG Ratio (TTM) | 7.08 | 0.48 |
| Price-to-Sales Ratio (P/S, TTM) | 4.28 | 0.74 |
| Price-to-Book Ratio (P/B, TTM) | 23.52 | 3.67 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 13.37 | 10.64 |
| EV-to-EBITDA (TTM) | 15.71 | 5.70 |
| EV-to-Sales (TTM) | 5.70 | 1.23 |
| EV-to-Free Cash Flow (TTM) | 17.82 | 17.79 |
Dividend Comparison
AMGN delivers a 3.41% dividend yield, blending income with growth, whereas THC appears to retain its profits, possibly to fund operations, R&D, or other growth initiatives.
| Symbol | AMGN | THC |
|---|---|---|
| Dividend Yield (TTM) | 3.41% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AMGN and THC, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- AMGN and THC both have debt-to-equity ratios above 3 (9.24 and 3.15), reflecting aggressive use of debt that can amplify gains but also increase vulnerability to rising rates.
| Symbol | AMGN | THC |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 1.78 |
| Quick Ratio (TTM) | 0.88 | 1.70 |
| Debt-to-Equity Ratio (TTM) | 9.24 | 3.15 |
| Debt-to-Assets Ratio (TTM) | 0.64 | 0.45 |
| Interest Coverage Ratio (TTM) | 3.19 | 5.80 |